Covid-booster response hope for most vulnerable

Covid-booster response hope for most vulnerable More than a million vulnerable people could improve their protection against Covid by taking a short break from medication after a booster jab, a trial suggests.

It found stopping the common immune-suppressing drug methotrexate for two weeks doubled spike antibody levels for up to 12 weeks.

Some people experienced disease flare-ups but no impact on quality of life. BBC News

See also:

• Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial (open access) The Lancet Respiratory Medicine
• No10 confirms it's watching emergence of two Omicron sub-variants responsible for UK Covid comeback The Daily Mail
• Possible link between blood clots and Covid symptoms investigated The Guardian